Early diagnosis of fibrodysplasia ossificans progressiva

Pediatrics

Volumn 121, Issue 5, 2008, Pages

  Kaplan, Frederick S ^a,h   Xu, Meiqi ^a   Glaser, David L ^a   Collins, Felicity ^b   Connor, Michael ^c   Kitterman, Joseph ^d   Sillence, David ^e   Zackai, Elaine ^f   Ravitsky, Vardit ^a   Zasloff, Michael ^a,g   Ganguly, Arupa ^a   Shore, Eileen M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF SYDNEY   (Australia)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

ACVR1; Bone morphogenetic protein; Fibrodysplasia ossificans progressiva; Heterotopic ossification; Malformed great toes

Indexed keywords

ACTIVIN RECEPTOR 1; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; DNA; GLYCINE; SERINE;

AMINO ACID SUBSTITUTION; ANAMNESIS; ARTICLE; CHILD; CLINICAL ARTICLE; CODON; CONGENITAL MALFORMATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DISEASE EXACERBATION; DNA SEQUENCE; EARLY DIAGNOSIS; EDEMA; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; HETEROTOPIC OSSIFICATION; HISTORY OF MEDICINE; HUMAN; INFANT; INVASIVE PROCEDURE; MALE; MISSENSE MUTATION; OSSIFYING MYOSITIS; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SOFT TISSUE; STANDARD; TISSUE INJURY; CLINICAL TRIAL; HALLUX; HALLUX VALGUS; MULTICENTER STUDY;

CHILD; CHILD, PRESCHOOL; EARLY DIAGNOSIS; FEMALE; HALLUX; HALLUX VALGUS; HUMANS; INFANT; MALE; MYOSITIS OSSIFICANS;

EID: 44449166223     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-1980     Document Type: Article

References (21)

1. Cohen RB, Hahn GV, Tabas J, et al. The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. J Bone Joint Surg. 1993;75(2):215-219
2. Rocke DM, Zasloff M, Peeper J, Cohen RB, Kaplan FS. Age and joint-specific risk of initial heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. Clin Orthop Rel Res. 1994;301:243-248
3. Kaplan FS, Strear CM, Zasloff MA. Radiographic and scintigraphic features of modeling and remodeling in the heterotopic skeleton of patients who have fibrodysplasia ossificans progressiva. Clin Orthop Rel Res. 1994;304:238-247
4. Mahboubi S, Glaser DL, Shore EM, Kaplan FS. Fibrodysplasia ossificans progressiva. Pediatr Radiol. 2001;31(5):307-314
5. Kaplan FS, Glaser DL, Shore EM, et al. The phenotype of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab. 2005;3(3-4):183-188
6. Kaplan FS, Glaser DL. Thoracic insufficiency syndrome in patients with fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab. 2005;3(3-4):213-216
7. Kaplan FS, Tabas J, Gannon FH, Finkel G, Hahn GV, Zasloff MA. The histopathology of fibrodysplasia ossificans progressiva: an endochondral process. J Bone Joint Surg. 1993; 75(2):220-230
8. Kitterman JA, Kantanie S, Rocke DM, Kaplan FS. Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva. Pediatrics. 2005;116. Available at: www.pediatrics.org/cgi/content/full/116/5/e654
9. Shore EM, Feldman GJ, Xu M, Kaplan FS. The genetics of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab. 2005;3(3-4):201-204
10. Kaplan FS, McCluskey W, Hahn G, Tabas J, Muenke M, Zasloff MA. Genetic transmission of fibrodysplasia ossificans progressiva. J Bone Joint Surg. 1993;75(8):1214-1220
11. Shore EM, Xu M, Feldman GJ, et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet. 2006;38(5): 525-527
12. Schaffer AA, Kaplan FS, Tracy MR, et al. Developmental anomalies of the cervical spine in patients with fibrodysplasia ossificans progressiva are distinctly different from those in patients with Klippel-Feil syndrome. Spine. 2005;30(12): 1379 -1385
13. Pignolo RJ, Suda RK, Kaplan FS. The fibrodysplasia ossificans progressiva lesion. Clin Rev Bone Miner Metab. 2005;3(3-4): 195-200
14. Ravitsky V. Disclosing individual genetic results to research participants. Am J Bioethics. 2006;6(6):8-17
15. Pelias MK. Genetic testing of children for adult-onset diseases: is testing in the child's best interest? Mt Sinai J Med. 2006;73(3): 605-608
16. Borry P, Stultiens L, Nys H, Cassiman JJ, Dierickx K. Presymp-tomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers. Clin Genet. 2006; 70(5):374-381
17. Lanchoney TF, Cohen RB, Rocke DM, Zasloff MA, Kaplan FS. Permanent heterotopic ossification at the injection site after diphtheria-tetanus- pertussis immunizations in children who have fibrodysplasia ossificans progressiva. J Pediatrics. 1995; 126(5 pt 1):762-764
18. Luchetti W, Cohen RB, Hahn GV, et al. Severe restriction in jaw movement after routine injection of local anesthetic in patients who have fibrodysplasia ossificans progressiva. Oral Surg OralMed Oral Pathol Oral Radiol Endod. 1996;81(1):21-25
19. Glaser DL, Rocke DM, Kaplan FS. Catastrophic falls in patients who have fibrodysplasia ossificans progressiva. Clin Orthop Rel Res. 1998;346:110-116
20. Glaser DL, Kaplan FS. Treatment considerations for the management of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab. 2005;3(3-4):243-250
21. Janoff HB, Muenke M, Johnson LO, et al. Fibrodysplasia ossificans progressiva in two half sisters: evidence for maternal mosaicism. Am J Med Genet. 1996;61(4):320-324